Gender medicine in gastroenterology

Israel Medical Association Journal

Volumn 13, Issue 4, 2011, Pages 244-246

  Niv, Yaron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Estrogen; Gastroenterology; Gender; Men; Sex hormones; Women

Indexed keywords

ANTIBIOTIC AGENT; CRANBERRY EXTRACT; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROTON PUMP INHIBITOR; SEX HORMONE;

APOPTOSIS; CANCER MORTALITY; CANCER SCREENING; CELL PROLIFERATION; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; ESTROGEN THERAPY; GASTROENTEROLOGY; GASTROINTESTINAL DISEASE; GENE FUNCTION; HELICOBACTER INFECTION; HIGH RISK POPULATION; HORMONE ACTION; HUMAN; OCCULT BLOOD TEST; REVIEW; SEX DIFFERENCE; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE;

ADENOMA; COLORECTAL NEOPLASMS; GASTROENTEROLOGY; GASTROINTESTINAL DISEASES; HUMANS; INTESTINAL POLYPS; RECEPTORS, ESTROGEN; SEX FACTORS;

EID: 79957612295     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Browning JD, Sreenarasimhaiah J. Gallstone disease. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th edn. Philadelphia: Saunders Elsevier, 2006: 1387-418.
2. Angulo P, Lindor KD. Primary billiary cirrhosis. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th edn. Philadelphia: Saunders Elsevier, 2006: 1885-98.
3. Richter JE. Gastroesophageal reflux disease and its complication. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th edn. Philadelphia: Saunders Elsevier, 2006: 905-36.
4. Tung BY, Kowdley KV. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th edn. Philadelphia: Saunders Elsevier, 2006: 1461-76.
5. Landau DA, Goldberg A, Levi Z, Levy Y, Niv Y, Bar-Dayan Y. The prevalence of gastrointestinal diseases in Israeli adolescents and its association with body mass index, sex, and Jewish ethnicity. J Clin Gastroenterol 2008; 42: 903-9.
6. Niv Y, Achiel K. Gastroenterology soldiers' clinic. Harefuah 2009; 148: 76-9 (Hebrew).
7. Cohen M, Sapoznikov B, Niv Y. Primary and secondary nonvariceal upper gastrointestinal bleeding. J Clin Gastroenterol 2007; 41: 810-13.
8. Kim JH, Boo YJ, Park JM, et al. Incidence and long-term outcome of young patients with gastric carcinoma according to sex. Does hormonal status affect prognosis? Arch Surg 2008; 143: 1062-7.
9. Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008; 103: 2394-400.
10. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol 2008; 103: 631-6.
11. Heetun ZS, Byrnes C, Neary P, O'Morain C. Reproduction in the patient with inflammatory bowel disease [Review]. Aliment Pharmacol Ther 2007; 26: 513-33.
12. Shmuely H, Yahav J, Samra Z, et al. Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor. Mol Nutr Food Res 2007; 51: 746-51.
13. Niv Y, Shamir R, Waked A. 13C urea breath test for diagnosis of Helicobacter pylori infection-gender difference of the results. Presented at the Israeli Gender Medicine Meeting, 2009.
14. McCashland TM, Brand R, Lyden E, de Garmo P; CORI Research Project. Gender differences in colorectal polyps and tumors. Am J Gastroenterol 2001; 96: 882-6.
15. Niv Y, Hazazi R, Levi Z, Fraser G. Screening colonoscopy for asymptomatic population; a meta-analysis. Dig Dis Sci 2008; 53: 3049-55.
16. Söderlund S, Granath F, Broström O, et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology 2010; 138: 1697-703.
17. Hendifar A, Yang D, Lenz F, et al. Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res 2009; 15: 6391-7.
18. Long MD, Martin CF, Galanko JA, Sandler RS. Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a populationbased case-control study. Am J Gastroenterol 2010; 105: 1843-50.
19. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007; 317: 124-7.
20. Konstantinopoulos PA, Kominea A, Vandoros G, et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003; 39: 1251-8.
21. Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 2005; 14: 17-21.
22. Wada-Hiraike O, Imamov O, Hiraike H, et al. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci USA 2006; 103: 2959-64.
23. Qiu Y, Waters CE, Lewis AE, Langman MJ, Eggo MC. Oestrogen induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 2002; 174: 369-77.
24. Hsu HH, Cheng SF, Wu CC, et al. Apoptotic effects of overexpressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signaling in a ligand-dependent manner. Chin J Physiol 2006; 49: 110-16.
25. Niv Y, Lev-El M, Fraser G, Abuksis G, Tamir A. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut 2002; 50: 33-7.
26. Levi Z, Birkenfeld S, Niv Y. Immunological fecal occult blood test screening for colorectal cancer in the Tel Aviv District, Israel. Int J Cancer. In press.